AI & Machine Learning– category –
-
Insilico Medicine to Showcase AI Drug Discovery Progress at Global Summits: Dr. Aliper to Keynote in Geneva, Dr. Zhavoronkov to Present Breakthroughs in Hong Kong
Insilico Medicine (via News-Medical.net) Unknown Overview Insilico Medicine announced that Co-Founder and President Dr. Alex Aliper will deliver a keynote on AI-powered drug discovery and generative AI in pharma R&D at the "AI for Go... -
AI Biologics Drug Discovery Accelerates: Earendil Labs Secures $787 Million for AI Platform Development
IntuitionLabs Unknown Overview By 2026, the convergence of AI and biologics drug discovery has dramatically accelerated, marking a significant inflection point in pharmaceutical R&D. Earendil Labs, a novel AI-driven biologics startup... -
Global M&A Surges to Record $2.83 Trillion in H1 2026, Fueled by AI Investment and US Deregulation, SpaceX Acquires AI Coding Firm Anysphere
BigGo Finance Unknown Overview Global M&A activity reached a record $2.83 trillion in the first half of 2026, driven by a surge in AI investment and U.S. deregulation. Mega-deals exceeding $10 billion sharply increased to 47, dominat... -
AI Startups Secure Major Funding: Nearfield Instruments Raises $380M for AI Chip Process Control, Tranxform Enters AI Chip Development, Lemrock Boosts Retail AI Agents with €6M Series A
Scouts by Yutori Unknown Overview Between July 4-6, 2026, AI startups announced significant funding rounds: Nearfield Instruments closed a $380 million Series D to expand its AI chip process control capabilities. Tranxform, founded by ex... -
Datasite Report: AI Becomes Indispensable in M&A Dealmaking, Trust and Governance Crucial for Competitive Advantage
GlobeNewswire USA Overview A new Datasite report reveals AI is now an indispensable infrastructure in M&A, with 62% of dealmakers deeming human-only decisions indefensible for complex transactions. As AI adoption accelerates, trust e... -
BIO Asia–Taiwan 2026 to Spotlight AI-Driven Drug Discovery, CDMO, and Cell & Gene Therapy, with XtalPi Detailing Robotic Automation Integration
GENE ONLINE|News & Opinion Blog Taiwan Overview BIO Asia–Taiwan 2026, scheduled for July 7, 2026, will center on AI-driven drug discovery, CDMO supply chain strategies, and the clinical application of cell and gene therapies. XtalPi Inc.... -
Texas Enacts “Responsible AI Governance Act,” Mandating Healthcare Entities Disclose AI Use in Clinical Decision-Making
Medium (Paul Rosenbaum) USA Overview Texas's "Responsible AI Governance Act" took effect on January 1, 2026, mandating healthcare organizations disclose their use of AI in clinical decision-making. This law aims to ensure transparency in... -
Assyro AI Offers Intelligent Regulatory Tool for CDMOs, Enabling Automated ICH Guideline Tracking and Rapid Module 3 Document Generation
Assyro AI USA Overview Assyro AI provides an intelligent regulatory tool for CDMOs (Contract Development and Manufacturing Organizations) in CMC/manufacturing roles. This tool assists with automated tracking of ICH quality guidelines, ra... -
Oracle Announces Vector Store Connector for Microsoft Agent Framework, Enabling RAG and Semantic Search for .NET Apps
Oracle developers blog USA Overview On July 7, 2026, Oracle announced support for its Oracle AI Database Vector Store Connector for the Microsoft Agent Framework. This connector allows .NET applications to leverage the Oracle AI Database... -
Taiwan’s Ministry of Economic Affairs to Support Over 20,000 Firms in AI Adoption by 2028, Raising Goal by 1.4x
Taipei Times Taiwan Overview On July 9, 2026, Taiwan's Ministry of Economic Affairs announced plans to support over 20,000 enterprises in adopting AI technology by 2028, a 1.4-fold increase from its previous target of 14,000 firms set la...
